nodes	percent_of_prediction	percent_of_DWPC	metapath
Dolasetron—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0393	0.052	CbGbCtD
Dolasetron—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.037	0.0489	CbGbCtD
Dolasetron—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.037	0.0489	CbGbCtD
Dolasetron—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.036	0.0475	CbGbCtD
Dolasetron—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0338	0.0447	CbGbCtD
Dolasetron—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0338	0.0447	CbGbCtD
Dolasetron—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0334	0.0442	CbGbCtD
Dolasetron—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0334	0.0442	CbGbCtD
Dolasetron—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0306	0.0404	CbGbCtD
Dolasetron—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0306	0.0404	CbGbCtD
Dolasetron—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0289	0.0381	CbGbCtD
Dolasetron—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.028	0.037	CbGbCtD
Dolasetron—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0264	0.0349	CbGbCtD
Dolasetron—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0256	0.0339	CbGbCtD
Dolasetron—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0253	0.0335	CbGbCtD
Dolasetron—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0253	0.0335	CbGbCtD
Dolasetron—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0243	0.0321	CbGbCtD
Dolasetron—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0232	0.0306	CbGbCtD
Dolasetron—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0232	0.0306	CbGbCtD
Dolasetron—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0229	0.0302	CbGbCtD
Dolasetron—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0215	0.0284	CbGbCtD
Dolasetron—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0215	0.0284	CbGbCtD
Dolasetron—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0194	0.0257	CbGbCtD
Dolasetron—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0194	0.0257	CbGbCtD
Dolasetron—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0168	0.0222	CbGbCtD
Dolasetron—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0163	0.0215	CbGbCtD
Dolasetron—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0147	0.0195	CbGbCtD
Dolasetron—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0147	0.0195	CbGbCtD
Dolasetron—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0141	0.0187	CbGbCtD
Dolasetron—HTR3A—nerve—acquired immunodeficiency syndrome	0.00212	0.225	CbGeAlD
Dolasetron—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000785	0.0834	CbGeAlD
Dolasetron—HTR3A—digestive system—acquired immunodeficiency syndrome	0.000616	0.0654	CbGeAlD
Dolasetron—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000599	0.0636	CbGeAlD
Dolasetron—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000589	0.0625	CbGeAlD
Dolasetron—HTR3A—blood—acquired immunodeficiency syndrome	0.000587	0.0623	CbGeAlD
Dolasetron—HTR3A—lung—acquired immunodeficiency syndrome	0.000515	0.0546	CbGeAlD
Dolasetron—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000477	0.0506	CbGeAlD
Dolasetron—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000459	0.0487	CbGeAlD
Dolasetron—HTR3A—brain—acquired immunodeficiency syndrome	0.000364	0.0387	CbGeAlD
Dolasetron—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000302	0.0321	CbGeAlD
Dolasetron—CYP2C9—blood—acquired immunodeficiency syndrome	0.000288	0.0305	CbGeAlD
Dolasetron—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.00023	0.0244	CbGeAlD
Dolasetron—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000227	0.0241	CbGeAlD
Dolasetron—CYP3A4—blood—acquired immunodeficiency syndrome	0.000219	0.0233	CbGeAlD
Dolasetron—CYP2D6—blood—acquired immunodeficiency syndrome	0.000216	0.0229	CbGeAlD
Dolasetron—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000208	0.000891	CcSEcCtD
Dolasetron—Confusional state—Delavirdine—acquired immunodeficiency syndrome	0.000208	0.000889	CcSEcCtD
Dolasetron—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000208	0.000889	CcSEcCtD
Dolasetron—Anaemia—Saquinavir—acquired immunodeficiency syndrome	0.000208	0.000889	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000208	0.000889	CcSEcCtD
Dolasetron—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000207	0.000884	CcSEcCtD
Dolasetron—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000884	CcSEcCtD
Dolasetron—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000883	CcSEcCtD
Dolasetron—Oedema—Delavirdine—acquired immunodeficiency syndrome	0.000206	0.000882	CcSEcCtD
Dolasetron—Anorexia—Efavirenz—acquired immunodeficiency syndrome	0.000206	0.000879	CcSEcCtD
Dolasetron—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.000878	CcSEcCtD
Dolasetron—Rash—Didanosine—acquired immunodeficiency syndrome	0.000205	0.000877	CcSEcCtD
Dolasetron—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000205	0.000876	CcSEcCtD
Dolasetron—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000205	0.000876	CcSEcCtD
Dolasetron—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000205	0.000876	CcSEcCtD
Dolasetron—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000872	CcSEcCtD
Dolasetron—Headache—Didanosine—acquired immunodeficiency syndrome	0.000204	0.000871	CcSEcCtD
Dolasetron—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000203	0.00087	CcSEcCtD
Dolasetron—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000203	0.000869	CcSEcCtD
Dolasetron—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000203	0.000868	CcSEcCtD
Dolasetron—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000203	0.000867	CcSEcCtD
Dolasetron—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000203	0.000867	CcSEcCtD
Dolasetron—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000203	0.000866	CcSEcCtD
Dolasetron—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000866	CcSEcCtD
Dolasetron—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000202	0.000865	CcSEcCtD
Dolasetron—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000864	CcSEcCtD
Dolasetron—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000202	0.000864	CcSEcCtD
Dolasetron—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000202	0.000863	CcSEcCtD
Dolasetron—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000202	0.000863	CcSEcCtD
Dolasetron—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000201	0.000861	CcSEcCtD
Dolasetron—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000201	0.00086	CcSEcCtD
Dolasetron—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000201	0.000859	CcSEcCtD
Dolasetron—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000201	0.000858	CcSEcCtD
Dolasetron—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.0002	0.000857	CcSEcCtD
Dolasetron—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.0002	0.000855	CcSEcCtD
Dolasetron—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0002	0.000854	CcSEcCtD
Dolasetron—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.0002	0.000853	CcSEcCtD
Dolasetron—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000199	0.000853	CcSEcCtD
Dolasetron—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000199	0.000851	CcSEcCtD
Dolasetron—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000851	CcSEcCtD
Dolasetron—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000851	CcSEcCtD
Dolasetron—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000199	0.000851	CcSEcCtD
Dolasetron—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000198	0.000848	CcSEcCtD
Dolasetron—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000198	0.000848	CcSEcCtD
Dolasetron—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000198	0.000848	CcSEcCtD
Dolasetron—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000845	CcSEcCtD
Dolasetron—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000197	0.000841	CcSEcCtD
Dolasetron—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000197	0.000841	CcSEcCtD
Dolasetron—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000197	0.000841	CcSEcCtD
Dolasetron—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000197	0.000841	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000196	0.00084	CcSEcCtD
Dolasetron—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000839	CcSEcCtD
Dolasetron—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000196	0.000839	CcSEcCtD
Dolasetron—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000834	CcSEcCtD
Dolasetron—Pain—Indinavir—acquired immunodeficiency syndrome	0.000195	0.000834	CcSEcCtD
Dolasetron—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000195	0.000833	CcSEcCtD
Dolasetron—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000833	CcSEcCtD
Dolasetron—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000195	0.000832	CcSEcCtD
Dolasetron—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000194	0.00083	CcSEcCtD
Dolasetron—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.000829	CcSEcCtD
Dolasetron—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000194	0.000829	CcSEcCtD
Dolasetron—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000194	0.000828	CcSEcCtD
Dolasetron—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000194	0.000828	CcSEcCtD
Dolasetron—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000194	0.000828	CcSEcCtD
Dolasetron—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000193	0.000826	CcSEcCtD
Dolasetron—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000193	0.000824	CcSEcCtD
Dolasetron—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000193	0.000824	CcSEcCtD
Dolasetron—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000192	0.000823	CcSEcCtD
Dolasetron—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000192	0.000822	CcSEcCtD
Dolasetron—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.000822	CcSEcCtD
Dolasetron—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000192	0.00082	CcSEcCtD
Dolasetron—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000819	CcSEcCtD
Dolasetron—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000819	CcSEcCtD
Dolasetron—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000192	0.000819	CcSEcCtD
Dolasetron—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000191	0.000816	CcSEcCtD
Dolasetron—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000191	0.000816	CcSEcCtD
Dolasetron—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00019	0.000814	CcSEcCtD
Dolasetron—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.00019	0.000811	CcSEcCtD
Dolasetron—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000809	CcSEcCtD
Dolasetron—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000807	CcSEcCtD
Dolasetron—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000188	0.000804	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000188	0.000804	CcSEcCtD
Dolasetron—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000802	CcSEcCtD
Dolasetron—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000187	0.000801	CcSEcCtD
Dolasetron—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000187	0.000801	CcSEcCtD
Dolasetron—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000801	CcSEcCtD
Dolasetron—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000187	0.000801	CcSEcCtD
Dolasetron—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000187	0.000799	CcSEcCtD
Dolasetron—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000187	0.000798	CcSEcCtD
Dolasetron—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000187	0.000798	CcSEcCtD
Dolasetron—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000186	0.000796	CcSEcCtD
Dolasetron—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000795	CcSEcCtD
Dolasetron—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.000795	CcSEcCtD
Dolasetron—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000185	0.000792	CcSEcCtD
Dolasetron—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000792	CcSEcCtD
Dolasetron—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000184	0.000789	CcSEcCtD
Dolasetron—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000788	CcSEcCtD
Dolasetron—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000184	0.000788	CcSEcCtD
Dolasetron—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000184	0.000788	CcSEcCtD
Dolasetron—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000184	0.000788	CcSEcCtD
Dolasetron—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000786	CcSEcCtD
Dolasetron—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000184	0.000786	CcSEcCtD
Dolasetron—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.000785	CcSEcCtD
Dolasetron—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000784	CcSEcCtD
Dolasetron—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.000783	CcSEcCtD
Dolasetron—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000781	CcSEcCtD
Dolasetron—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000781	CcSEcCtD
Dolasetron—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000183	0.000781	CcSEcCtD
Dolasetron—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000779	CcSEcCtD
Dolasetron—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000777	CcSEcCtD
Dolasetron—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000776	CcSEcCtD
Dolasetron—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000181	0.000775	CcSEcCtD
Dolasetron—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000772	CcSEcCtD
Dolasetron—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000181	0.000772	CcSEcCtD
Dolasetron—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000771	CcSEcCtD
Dolasetron—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000771	CcSEcCtD
Dolasetron—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.00018	0.000769	CcSEcCtD
Dolasetron—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000179	0.000767	CcSEcCtD
Dolasetron—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000764	CcSEcCtD
Dolasetron—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000179	0.000763	CcSEcCtD
Dolasetron—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000178	0.000763	CcSEcCtD
Dolasetron—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000762	CcSEcCtD
Dolasetron—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000178	0.0189	CbGeAlD
Dolasetron—Rash—Stavudine—acquired immunodeficiency syndrome	0.000178	0.000761	CcSEcCtD
Dolasetron—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.00076	CcSEcCtD
Dolasetron—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000178	0.00076	CcSEcCtD
Dolasetron—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00076	CcSEcCtD
Dolasetron—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000759	CcSEcCtD
Dolasetron—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.000759	CcSEcCtD
Dolasetron—Headache—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000756	CcSEcCtD
Dolasetron—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000755	CcSEcCtD
Dolasetron—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000754	CcSEcCtD
Dolasetron—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000754	CcSEcCtD
Dolasetron—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000754	CcSEcCtD
Dolasetron—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000176	0.000753	CcSEcCtD
Dolasetron—Rash—Abacavir—acquired immunodeficiency syndrome	0.000175	0.00075	CcSEcCtD
Dolasetron—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000175	0.0186	CbGeAlD
Dolasetron—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000175	0.000749	CcSEcCtD
Dolasetron—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000749	CcSEcCtD
Dolasetron—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000749	CcSEcCtD
Dolasetron—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000748	CcSEcCtD
Dolasetron—Headache—Abacavir—acquired immunodeficiency syndrome	0.000174	0.000745	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.000743	CcSEcCtD
Dolasetron—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000742	CcSEcCtD
Dolasetron—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000737	CcSEcCtD
Dolasetron—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000734	CcSEcCtD
Dolasetron—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000172	0.000733	CcSEcCtD
Dolasetron—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000171	0.0182	CbGeAlD
Dolasetron—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000732	CcSEcCtD
Dolasetron—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000732	CcSEcCtD
Dolasetron—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000729	CcSEcCtD
Dolasetron—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000729	CcSEcCtD
Dolasetron—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000727	CcSEcCtD
Dolasetron—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.000727	CcSEcCtD
Dolasetron—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000725	CcSEcCtD
Dolasetron—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000169	0.000724	CcSEcCtD
Dolasetron—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000721	CcSEcCtD
Dolasetron—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000169	0.0179	CbGeAlD
Dolasetron—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000168	0.000719	CcSEcCtD
Dolasetron—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.000718	CcSEcCtD
Dolasetron—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000718	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000167	0.000715	CcSEcCtD
Dolasetron—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000714	CcSEcCtD
Dolasetron—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000166	0.000709	CcSEcCtD
Dolasetron—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000705	CcSEcCtD
Dolasetron—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.000703	CcSEcCtD
Dolasetron—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.000701	CcSEcCtD
Dolasetron—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000164	0.0007	CcSEcCtD
Dolasetron—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.0007	CcSEcCtD
Dolasetron—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.0007	CcSEcCtD
Dolasetron—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000698	CcSEcCtD
Dolasetron—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000698	CcSEcCtD
Dolasetron—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000698	CcSEcCtD
Dolasetron—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000697	CcSEcCtD
Dolasetron—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000697	CcSEcCtD
Dolasetron—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000162	0.000694	CcSEcCtD
Dolasetron—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000691	CcSEcCtD
Dolasetron—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000161	0.00069	CcSEcCtD
Dolasetron—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.00016	0.000682	CcSEcCtD
Dolasetron—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.000682	CcSEcCtD
Dolasetron—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.000679	CcSEcCtD
Dolasetron—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.000677	CcSEcCtD
Dolasetron—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000673	CcSEcCtD
Dolasetron—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000672	CcSEcCtD
Dolasetron—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000671	CcSEcCtD
Dolasetron—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.000671	CcSEcCtD
Dolasetron—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000668	CcSEcCtD
Dolasetron—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000156	0.000668	CcSEcCtD
Dolasetron—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000667	CcSEcCtD
Dolasetron—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000666	CcSEcCtD
Dolasetron—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.000661	CcSEcCtD
Dolasetron—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000155	0.000661	CcSEcCtD
Dolasetron—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000155	0.000661	CcSEcCtD
Dolasetron—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.000659	CcSEcCtD
Dolasetron—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.000657	CcSEcCtD
Dolasetron—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000652	CcSEcCtD
Dolasetron—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000152	0.000651	CcSEcCtD
Dolasetron—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.00065	CcSEcCtD
Dolasetron—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.000648	CcSEcCtD
Dolasetron—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000647	CcSEcCtD
Dolasetron—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000151	0.000646	CcSEcCtD
Dolasetron—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000151	0.000645	CcSEcCtD
Dolasetron—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000645	CcSEcCtD
Dolasetron—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000645	CcSEcCtD
Dolasetron—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000642	CcSEcCtD
Dolasetron—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00064	CcSEcCtD
Dolasetron—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00064	CcSEcCtD
Dolasetron—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000633	CcSEcCtD
Dolasetron—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000631	CcSEcCtD
Dolasetron—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.000624	CcSEcCtD
Dolasetron—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.000624	CcSEcCtD
Dolasetron—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000621	CcSEcCtD
Dolasetron—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000621	CcSEcCtD
Dolasetron—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000617	CcSEcCtD
Dolasetron—Rash—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000615	CcSEcCtD
Dolasetron—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000144	0.000615	CcSEcCtD
Dolasetron—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000612	CcSEcCtD
Dolasetron—Headache—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000611	CcSEcCtD
Dolasetron—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000143	0.00061	CcSEcCtD
Dolasetron—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.000603	CcSEcCtD
Dolasetron—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000601	CcSEcCtD
Dolasetron—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.000595	CcSEcCtD
Dolasetron—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000592	CcSEcCtD
Dolasetron—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000592	CcSEcCtD
Dolasetron—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000585	CcSEcCtD
Dolasetron—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000136	0.000583	CcSEcCtD
Dolasetron—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000581	CcSEcCtD
Dolasetron—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000136	0.000581	CcSEcCtD
Dolasetron—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000578	CcSEcCtD
Dolasetron—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000578	CcSEcCtD
Dolasetron—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000577	CcSEcCtD
Dolasetron—CYP2D6—brain—acquired immunodeficiency syndrome	0.000134	0.0142	CbGeAlD
Dolasetron—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000563	CcSEcCtD
Dolasetron—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000558	CcSEcCtD
Dolasetron—Rash—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000556	CcSEcCtD
Dolasetron—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.000556	CcSEcCtD
Dolasetron—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000555	CcSEcCtD
Dolasetron—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000553	CcSEcCtD
Dolasetron—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000552	CcSEcCtD
Dolasetron—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000126	0.000539	CcSEcCtD
Dolasetron—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000537	CcSEcCtD
Dolasetron—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000537	CcSEcCtD
Dolasetron—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.00053	CcSEcCtD
Dolasetron—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000519	CcSEcCtD
Dolasetron—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000514	CcSEcCtD
Dolasetron—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000514	CcSEcCtD
Dolasetron—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.000512	CcSEcCtD
Dolasetron—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000511	CcSEcCtD
Dolasetron—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000116	0.000495	CcSEcCtD
Dolasetron—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000495	CcSEcCtD
Dolasetron—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000495	CcSEcCtD
Dolasetron—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000492	CcSEcCtD
Dolasetron—Rash—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000472	CcSEcCtD
Dolasetron—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000472	CcSEcCtD
Dolasetron—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000469	CcSEcCtD
